INVESTIGATIONAL PRODUCT for Atrial fibrillation: Side Effects & Safety Data
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
There are 8 adverse event reports in the FDA FAERS database where INVESTIGATIONAL PRODUCT was used for Atrial fibrillation.
Most Reported Side Effects for INVESTIGATIONAL PRODUCT
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Febrile neutropenia | 241 | 4.5% | 29 | 215 |
| Pneumonia | 229 | 4.3% | 69 | 209 |
| Acute kidney injury | 198 | 3.7% | 35 | 185 |
| Pyrexia | 189 | 3.5% | 17 | 171 |
| Anaemia | 176 | 3.3% | 21 | 151 |
| Diarrhoea | 170 | 3.2% | 28 | 131 |
| Sepsis | 168 | 3.1% | 66 | 147 |
| Dyspnoea | 156 | 2.9% | 26 | 124 |
| Nausea | 134 | 2.5% | 14 | 93 |
| Hypotension | 130 | 2.4% | 22 | 116 |
| Vomiting | 128 | 2.4% | 15 | 99 |
| Neutropenia | 126 | 2.3% | 16 | 68 |
| Dehydration | 113 | 2.1% | 8 | 103 |
| Fatigue | 111 | 2.1% | 18 | 77 |
| Death | 102 | 1.9% | 102 | 33 |
Other Indications for INVESTIGATIONAL PRODUCT
Non-small cell lung cancer (288)
Acute myeloid leukaemia (210)
Product used for unknown indication (197)
Malignant melanoma (181)
Breast cancer (168)
Plasma cell myeloma (151)
Chronic lymphocytic leukaemia (104)
Cardiac failure chronic (103)
Neoplasm (101)
Chronic obstructive pulmonary disease (89)
Other Drugs Used for Atrial fibrillation
RIVAROXABAN (52,584)
DABIGATRAN ETEXILATE (20,492)
APIXABAN (10,500)
AMIODARONE (9,083)
WARFARIN (8,680)
EDOXABAN (3,855)
ASPIRIN (2,993)
DOFETILIDE (2,439)
PRADAXA (2,325)
METOPROLOL (1,542)